Hear from the ERS Pulmonary vascular diseases assembly
We spoke to ERS officers who specialise in this disease area to find out what you can expect from the hybrid Congress and which programme highlights should not be missed. See what they told us:

Anton Vonk Noordegraaf – Head
Q: What are you most looking forward to at this year’s Congress in the pulmonary vascular diseases field?
A: This year we faced many therapeutical breakthroughs in the treatment of pulmonary arterial hypertension, opening up the horizon of novel treatments in this area which have great promise for patients suffering from pulmonary hypertension. The ERS Congress in Barcelona will show the most recent results and also indicate what is coming next.
Q: Is there a specific session in this track that should not be missed?
A: A highlight will be the presentation of the ERS/ESC guideline on the diagnosis and treatment of pulmonary hypertension 2022. Novel insights on the treatment of pulmonary embolism in complex situations such as cancer will be shared. Finally, postgraduate courses, hand on courses dedicated to the correct performance of right heart catheterisation and informal meetings of the young members of our assembly will offer an excellent opportunity for our young members of our assembly to grow in the field, learn from colleagues and meet new friends.